BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 27368924)

  • 1. Arterio-portal shunts in the cirrhotic liver: perfusion computed tomography for distinction of arterialized pseudolesions from hepatocellular carcinoma.
    Fischer MA; Marquez HP; Gordic S; Leidner B; Klotz E; Aspelin P; Alkadhi H; Brismar TB
    Eur Radiol; 2017 Mar; 27(3):1074-1080. PubMed ID: 27368924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.
    Fischer MA; Kartalis N; Grigoriadis A; Loizou L; Stål P; Leidner B; Aspelin P; Brismar TB
    Eur Radiol; 2015 Nov; 25(11):3123-32. PubMed ID: 25903707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Ratti L; Alberzoni C; Leone EB; Meloni F; Valsecchi MG; Fazio F
    Acad Radiol; 2008 Jul; 15(7):919-27. PubMed ID: 18572129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Texture Analysis Parameter for Response Prediction in Patients with Hepatocellular Carcinoma Undergoing Drug-eluting Bead Transarterial Chemoembolization (DEB-TACE) Using Biphasic Contrast-enhanced CT Image Data: Correlation with Liver Perfusion CT.
    Kloth C; Thaiss WM; Kärgel R; Grimmer R; Fritz J; Ioanoviciu SD; Ketelsen D; Nikolaou K; Horger M
    Acad Radiol; 2017 Nov; 24(11):1352-1363. PubMed ID: 28652049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomography perfusion imaging for monitoring transarterial chemoembolization of hepatocellular carcinoma.
    Marquez HP; Karalli A; Haubenreisser H; Mathew RP; Alkadhi H; Brismar TB; Henzler T; Fischer MA
    Eur J Radiol; 2017 Jun; 91():160-167. PubMed ID: 28629564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nontumorous arterioportal shunt mimicking hypervascular tumor in cirrhotic liver: two-phase spiral CT findings.
    Kim TK; Choi BI; Han JK; Chung JW; Park JH; Han MC
    Radiology; 1998 Sep; 208(3):597-603. PubMed ID: 9722834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of tumour associated neovascularisation in patients with liver cirrhosis and hepatocellular carcinoma: role of dynamic-CT perfusion imaging.
    Ippolito D; Capraro C; Casiraghi A; Cestari C; Sironi S
    Eur Radiol; 2012 Apr; 22(4):803-11. PubMed ID: 22086560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
    Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
    Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
    Byun JH; Kim TK; Lee CW; Lee JK; Kim AY; Kim PN; Ha HK; Lee MG
    Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of tumor vascularization with functional computed tomography perfusion imaging in patients with cirrhotic liver disease.
    Li JP; Zhao DL; Jiang HJ; Huang YH; Li DQ; Wan Y; Liu XD; Wang JE
    Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):43-9. PubMed ID: 21269934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
    Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
    Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
    Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
    Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of CT-perfusion map as indicator of tumor response to transarterial chemoembolization and radiofrequency ablation in HCC patients.
    Ippolito D; Fior D; Bonaffini PA; Capraro C; Leni D; Corso R; Sironi S
    Eur J Radiol; 2014 Sep; 83(9):1665-71. PubMed ID: 24962900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterioportal shunts not directly related to hepatocellular carcinoma: findings on CT during hepatic arteriography, CT arterial portography and dual phase spiral CT.
    Park CM; Cha SH; Kim DH; Choi JA; Cha IH; Kim YH; Chung KB; Suh WH
    Clin Radiol; 2000 Jun; 55(6):465-70. PubMed ID: 10873693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative evaluation of hepatocellular carcinoma: combined use of CT with arterial portography and hepatic arteriography.
    Kim HC; Kim TK; Sung KB; Yoon HK; Kim PN; Ha HK; Kim AY; Kim HJ; Lee MG
    AJR Am J Roentgenol; 2003 Jun; 180(6):1593-9. PubMed ID: 12760926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed tomography during arterial portography under temporary balloon occlusion of the hepatic artery: evaluation of pseudolesions caused by arterio-portal venous shunts.
    Koizumi J; Kurata T; Yamashita T; Kominami M; Fujiwara H; Narimatsu Y; Hiramatsu K
    Abdom Imaging; 2000; 25(6):583-6. PubMed ID: 11029088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfusion-CT analysis for assessment of hepatocellular carcinoma lesions: diagnostic value of different perfusion maps.
    Hatzidakis A; Perisinakis K; Kalarakis G; Papadakis A; Savva E; Ippolito D; Karantanas A
    Acta Radiol; 2019 May; 60(5):561-568. PubMed ID: 30114926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small hypervascular enhancing lesions on arterial phase images of multiphase dynamic computed tomography in cirrhotic liver: fate and implications.
    Hwang SH; Yu JS; Kim KW; Kim JH; Chung JJ
    J Comput Assist Tomogr; 2008; 32(1):39-45. PubMed ID: 18303286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: assessment of tumor-related vascularization.
    Ippolito D; Sironi S; Pozzi M; Antolini L; Invernizzi F; Ratti L; Leone EB; Fazio F
    Eur J Radiol; 2010 Jan; 73(1):148-52. PubMed ID: 19054640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
    Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
    Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.